Endotoxin release from Escherichia coli after exposure to tobramycin: Dose-dependency and reduction in cefuroxime-induced endotoxin release

Clinical Microbiology and Infection

Volumn 6, Issue 2, 2000, Pages 74-81

  Sjolin J ^a   Goscinski, G ^a   Lundholm, M ^a   Bring, J ^b   Odenholt, I ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cefuroxime; Endotoxin; Tobramycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFUROXIME; CHROMOGENIC SUBSTRATE; ESCHERICHIA COLI ENDOTOXIN; PENICILLIN BINDING PROTEIN; TOBRAMYCIN;

ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG BINDING; DRUG EXPOSURE; ESCHERICHIA COLI; INOCULATION; LIMULUS LYSATE TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LIMULUS; LIMULUS AMOEBOCYTE;

EID: 0034143218     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00025.x     Document Type: Article

References (39)

1. Knaus WA, Harrell FE, Fisher CJ et al. The clinical evaluation of new drugs for sepsis: a prospective study design based on survival analysis. JAMA 1993; 270: 1233-41.
2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davies CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273: 117-23.
3. Salvo I, de Cian W, Musicco M et al. The Italian sepsis study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995; 21: S244-9.
4. Darville T, Giroir B, Jacobs R. The systemic inflammatory response (SIRS): immunology and potential immunotherapy. Infection 1993; 21: 279-90.
5. Lynn WA, Cohen J. Adjunctive therapy for septic shock: a review of experimental approaches. Clin Infect Dis 1995; 20: 143-58.
6. Andersen BM, Solberg O. Endotoxin liberation and invasivity of Neisseria meningitidis. Scand J Infect Dis 1984; 16: 247-54.
7. Goto H, Nakamura S. Liberation of endotoxin from Escherichia coli by addition of antibiotics. Japan J Exp Med 1979; 50: 35-43.
8. Hurley JC. Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Safety 1995; 12: 183-95.
9. Shenep JL, Mogan KA. Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1984; 150: 380-7.
10. Stevens DL, Bryant AE, Hackett SP. Gram-positive shock. Curr Opin Infect Dis 1992; 5: 355-63.
11. Weidemann B, Brade H, Rietschl ET et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immunol 1994; 62: 4709-15.
12. Dofferhoff ASM, Nijland JH, de Vries-Hospers HG, Mulder PO, Weits J, Bom VJ. Effects of different types of combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in vitro and in vivo study. Scand J Infect Dis 1991; 23: 745-54.
13. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJ, Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-91.
14. Shenep JL, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012-8.
15. Jackson JJ, Kropp H. Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033-41.
16. Bingen E, Goury V, Bennani H, Lambert-Zechovsky N, Aujard Y, Darbord JC. Bactericidal activity of β-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release. J Antimicrob Chemother 1992; 30: 165-72.
17. van den Berg C, de Neeling AJ, Schot CS, Hustinx WNM, Wemer J, de Wildt DJ. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis 1992; 24: 619-27.
18. Kadurugamuwa JL, Lam JS, Beveridge TJ. Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Antimicrob Agents Chemother 1993; 37: 715-21.
19. Moore RA, Bates NC, Hancock RE. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother 1986; 29: 496-500.
20. Prins JM, van Deventer SJH, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-8.
21. Issekutz AC. Removal of Gram-negative endotoxin from solutions by affinity chromatography. J Immunol Methods 1983; 61: 275-81.
22. Young LS. Sepsis syndrome. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone, 1995: 690-705.
23. Barza M, Ioannidis JPA, Cappelleri JC, Lau J. Single or multiple doses of aminoglycosides: a meta-analysis. BMJ 1996; 312: 338-44.
24. Hollender LF, Bahnini J, de Manzini N et al. A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections. J Antimicrob Chemother 1989; 23: 773-83.
25. Nachum R, Berzofsky RN. Chromogenic Limulus amoebocyte lysate assay for rapid detection of Gram negative bacteriuria. J Clin Microbiol 1985; 21: 759-63.
26. Manly BFJ, The design and analysis of research studies. Cambridge: Cambridge University Press, 1992.
27. Neu HC. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med 1985; 79 (Suppl. 2A): S2-13.
28. Dofferhoff ASM, Esselink MT, de Vries-Hospers HG et al. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumor necrosis factor by human monocytes. J Antimicrob Chemother 1993; 31: 373-84.
29. Kapusnik JE, Hackbarth CJ, Chambers HF, Carpenter T, Sande MA. Single, large daily dosing vs intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia. J Infect Dis 1988; 158: 7-12.
30. Artenstein AW, Cross AS. Inhibition of endotoxin reactivity by aminoglycosides. J Antimicrob Chemother 1989; 24: 826-8.
31. Foca A, Matera G, Iannello D, Berlinghieri MC, Liberto MC. Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide. Antimicrob Agents Chemother 1991; 35: 2161-4.
32. Kusser WC, Ishiguro, EE. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli. Antimicrob Agents Chemother 1988; 32: 1247-50.
33. Morrison DC, Bucklin SE, Leeson MC, Norimatsu M. Contribution of soluble endotoxin released from gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice. J Endotox Res 1996; 3: 237-43.
34. Arditi M, Ables L, Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis 1989; 160: 1005-11.
35. Mock CN, Jurkovich GJ, Dries DJ, Maier RV. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Surg 1995; 130: 1234-41.
36. Mauray E, Barakett V, Blanchard H et al. Circulating endotoxin during initial antibiotic treatment of severe Gram-negative bacteremic infections. J Infect Dis 1998; 178: 270-3.
37. van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76: 2520-6.
38. Eidelmann LA, Sprung CL. Why have new effective therapies for sepsis not been developed? Crit Care Med 1994; 8: 1330-4.
39. Sjölin J. Immunomodulation of the systemic inflammatory response in septic shock. In: Risberg B. ed. Trauma care: an update. Mölndal: PR-Offset AB, 1996: 162-79.